Scientists probe immune cells to unlock Scleroderma's scarring secrets
NCT ID NCT03559465
Summary
This study aimed to understand how a type of immune cell, called B lymphocytes, might contribute to the scarring (fibrosis) seen in systemic sclerosis (scleroderma). Researchers compared cells from 71 people, including patients and healthy volunteers, to see how patient B cells interact with scar-forming cells. The goal was to gather knowledge about the disease process, not to test a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Claude Huriez, CHU
Lille, France
Conditions
Explore the condition pages connected to this study.